Paraneoplastic sensory ganglionopathy (Q85101): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/46072886 / rank | |||
Normal rank | |||
Revision as of 10:27, 15 August 2026
Paraneoplastic sensory neuronopathy occurs in patients with cancer and is triggered by immune mechanisms. It has a subacute onset, severe sensory loss resulting in ataxia. The onset can be asymmetric, often beginning in the arms and associated with neuropathic pain. The motor system is rarely involved. Once established it has a chronic and unremitting course disabling the patient. SSN occurs in association with several cancer types, in particular SCLC. Associated neural autoantibodies are of the onconeural type, predominantly anti Hu.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_46072886 |
||
| English | Paraneoplastic sensory ganglionopathy |
Paraneoplastic sensory neuronopathy occurs in patients with cancer and is triggered by immune mechanisms. It has a subacute onset, severe sensory loss resulting in ataxia. The onset can be asymmetric, often beginning in the arms and associated with neuropathic pain. The motor system is rarely involved. Once established it has a chronic and unremitting course disabling the patient. SSN occurs in association with several cancer types, in particular SCLC. Associated neural autoantibodies are of the onconeural type, predominantly anti Hu. |
